Literature DB >> 12504663

Heparanase gene expression and its correlation with spontaneous apoptosis in hepatocytes of cirrhotic liver and carcinoma.

M Ikeguchi1, Y Hirooka, N Kaibara.   

Abstract

Heparanase (hep) degrades heparan sulphate proteoglycans (HSPGs), which are the main components of the extracellular matrix. This process has been considered as the first step of tumour invasion or metastasis. However, HSPGs play an important role in signal transduction. Thus, the degradation of HSPGs by hep may suppress tumour cell growth. In the present study, we investigated the clinicopathological importance of enhanced hep mRNA expression in 48 hepatocellular carcinomas (HCCs) and in 48 non-cancerous liver samples obtained from the same patients by quantitative real-time reverse transcriptase polymerase chain reaction (RT-PCR). Spontaneous apoptosis in the hepatocytes was evaluated by immunohistochemistry. The relative hep mRNA expression levels were described as hep/glyceraldehyde-3-phosphate dehydrogenase (GAPDH) ratios. The hep mRNA levels of HCCs were significantly lower than those of non-cancerous livers (P<0.001). Hep mRNA levels decreased with increasing liver fibrosis. A significant positive correlation between hep gene expression and spontaneous apoptosis was detected. Hep expression in the tumours did not correlate with tumour differentiation or with tumour stage. However, low hep gene expression was associated with a poor disease-free survival of the patients. Thus, hep gene expression may play an important role in programmed cell death and this gene expression may be lost during the malignant transformation of hepatocytes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12504663     DOI: 10.1016/s0959-8049(02)00558-0

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  10 in total

Review 1.  The advancements of heparanase in fibrosis.

Authors:  Qianying Lv; Ji Zeng; Long He
Journal:  Int J Mol Epidemiol Genet       Date:  2016-11-30

2.  Heparanase and basic fibroblast growth factor are co-expressed in malignant mesothelioma.

Authors:  Ben Davidson; Lina Vintman; Eyal Zcharia; Carlos Bedrossian; Aasmund Berner; Søren Nielsen; Neta Ilan; Israel Vlodavsky; Reuven Reich
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

3.  Heparanase Expression Propagates Liver Damage in CCL4-Induced Mouse Model.

Authors:  Xiaowen Cheng; Juan Jia; Tianji Zhang; Xiao Zhang; Israel Vlodavsky; Jin-Ping Li
Journal:  Cells       Date:  2022-06-27       Impact factor: 7.666

Review 4.  Heparanase and hepatocellular carcinoma: promoter or inhibitor?

Authors:  Shuo Dong; Xiong-Zhi Wu
Journal:  World J Gastroenterol       Date:  2010-01-21       Impact factor: 5.742

5.  Small RNA interference-mediated gene silencing of heparanase abolishes the invasion, metastasis and angiogenesis of gastric cancer cells.

Authors:  Liduan Zheng; Guosong Jiang; Hong Mei; Jiarui Pu; Jihua Dong; Xiaohua Hou; Qiangsong Tong
Journal:  BMC Cancer       Date:  2010-02-05       Impact factor: 4.430

6.  Upregulation of heparanase in high-glucose-treated endothelial cells promotes endothelial cell migration and proliferation and correlates with Akt and extracellular-signal-regulated kinase phosphorylation.

Authors:  Ling Yuan; Jie Hu; Yan Luo; QingYun Liu; Tao Li; Christopher R Parish; Craig Freeman; XiaoBo Zhu; Wei Ma; XuTing Hu; HongHua Yu; ShiBo Tang
Journal:  Mol Vis       Date:  2012-06-20       Impact factor: 2.367

7.  Heparanase and macrophage interplay in the onset of liver fibrosis.

Authors:  Maria Francesca Secchi; Marika Crescenzi; Valentina Masola; Francesco Paolo Russo; Annarosa Floreani; Maurizio Onisto
Journal:  Sci Rep       Date:  2017-11-02       Impact factor: 4.379

Review 8.  The role of reactive oxygen species in apoptosis of the diabetic kidney.

Authors:  F A D T G Wagener; D Dekker; J H Berden; A Scharstuhl; J van der Vlag
Journal:  Apoptosis       Date:  2009-12       Impact factor: 4.677

9.  Allele loss and down-regulation of heparanase gene are associated with the progression and poor prognosis of hepatocellular carcinoma.

Authors:  Guo-Liang Huang; Bin-Kui Li; Mei-Yin Zhang; Rong-Rong Wei; Yun-Fei Yuan; Ming Shi; Xiao-Qian Chen; Long Huang; Hui-Zhong Zhang; Wanqing Liu; Bi-Jun Huang; Honghua Li; Xiao-Feng Zheng; Xian-Rong Luo; Hui-Yun Wang
Journal:  PLoS One       Date:  2012-08-31       Impact factor: 3.240

10.  Heparanase Inhibition Prevents Liver Steatosis in E0 Mice.

Authors:  Safa Kinaneh; Walaa Hijaze; Lana Mansour-Wattad; Rawan Hammoud; Hisam Zaidani; Aviva Kabala; Shadi Hamoud
Journal:  J Clin Med       Date:  2022-03-17       Impact factor: 4.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.